Searched for
BROKERAGES ON GLAND PHARMA
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
- Small & midcaps rally! Coforge, Ola Electric, FirstCry & other stocks jump up to 7%Small and midcap stocks rose sharply on Tuesday, lifting broader markets and outperforming benchmarks. Coforge led midcap gains, while Ola ...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Gland Pharma shares jump 11% as Q4 profit soars 97% YoY, co announces Rs 20/share final dividendShares of Gland Pharma rallied on Monday after the company reported a 97% YoY surge in Q4 profit and strong revenue growth, driven by its C...
- Ceasefire calm or chaos? 50 stocks that brokerages expect to rally after Iran truceA two-week US-Iran ceasefire has sparked a relief rally in Indian equities, though its sustainability is questioned as oil prices rebound. ...
- Gland Pharma shares rally 6% as brokerages lift ratings, target prices; here's whyGland Pharma shares surged after strong Q1 results and positive commentary from brokerages citing a turnaround at its European unit Cenexi....
- Buy Gland Pharma, target price Rs 1,970: Motilal Oswal SecuritiesMotilal Oswal Securities recommends buying Gland Pharma stock. They predict a target price of Rs 1970. The brokerage expects Gland Pharma's...
- Hold Gland Pharma, target price Rs 1689: Sharekhan by BNP ParibasGland Pharma, incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 26597.18 Crore) operating in Pharmaceuticals...
- Hot Stocks: Gland Pharma, Mirza International and Agro Tech Foods could give 19-30% returnOffices and schools have opened, which creates an incremental demand for shoes and that benefits the shoe manufacturers, the brokerage said...
- Gland Pharma falls 5% after announcing Cenexi Group acquisitionCenexi, along with its subsidiaries, is engaged primarily in the business of Contract Development & Manufacturing Organisation (CDMO) of ph...
- Hot Stocks: Brokerage view on Gland Pharma, Aditya Birla Fashion and PDSThe deal appears complementary to Gland in terms of EU market access, branded pharma customer base and some technologies, the brokerage sai...
- Hold Gland Pharma, target price Rs 2100: Axis SecuritiesGland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 31075.06 Crore) operating in Pharmaceut...
- Hot Stocks: Global brokerages on UltraTech Cement, Dalmia Bharat, Eicher Motors and Gland PharmaCLSA maintained a buy rating on Eicher Motors with a target price of Rs 4154. The stock closed at Rs 3363 on 22 August. The company is seei...
- Buy Gland Pharma, target price Rs 4930: Emkay GlobalGland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 54285.62 Crore) operating in Pharmaceut...
- First up: Jefferies puts buy rating on Gland, Laurus LabsJefferies has initiated coverage on Gland Pharma and Laurus Labs with buy ratings as it believes that Indian contract development and manuf...
- Jefferies sees up to 21% upside in these two pharma stocksIt has a target of Rs 4,566 on Gland Pharma, valuing the stock at 36.5 times FY24 EPS, in line with its historical one-year forward of 37 t...
- Buy Gland Pharma, target price Rs 4460: Motilal OswalGland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 62199.38 Crore) operating in Pharmaceut...
- The Indian IPO that saw tepid bids 4 months ago is spinning money nowWhile many analysts believe the stock is priced to perfection, some others project it to rise up to Rs 3,000, which would mean a 100 per ce...
- Gland Pharma IPO off to lacklustre start, subscribed 4% on Day 1The IPO is a mix of a fresh issue of shares worth Rs 1,250 crore and an offer for sale of up to 3.49 crore shares.
Load More
